1. Home
  2. PFO vs IRWD Comparison

PFO vs IRWD Comparison

Compare PFO & IRWD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PFO
  • IRWD
  • Stock Information
  • Founded
  • PFO 1991
  • IRWD 1998
  • Country
  • PFO United States
  • IRWD United States
  • Employees
  • PFO N/A
  • IRWD N/A
  • Industry
  • PFO Finance Companies
  • IRWD Biotechnology: Pharmaceutical Preparations
  • Sector
  • PFO Finance
  • IRWD Health Care
  • Exchange
  • PFO Nasdaq
  • IRWD Nasdaq
  • Market Cap
  • PFO 116.6M
  • IRWD 97.4M
  • IPO Year
  • PFO N/A
  • IRWD 2010
  • Fundamental
  • Price
  • PFO $9.33
  • IRWD $0.77
  • Analyst Decision
  • PFO
  • IRWD Buy
  • Analyst Count
  • PFO 0
  • IRWD 5
  • Target Price
  • PFO N/A
  • IRWD $4.94
  • AVG Volume (30 Days)
  • PFO 31.8K
  • IRWD 2.6M
  • Earning Date
  • PFO 01-01-0001
  • IRWD 08-07-2025
  • Dividend Yield
  • PFO 6.51%
  • IRWD N/A
  • EPS Growth
  • PFO N/A
  • IRWD N/A
  • EPS
  • PFO N/A
  • IRWD N/A
  • Revenue
  • PFO N/A
  • IRWD $317,676,000.00
  • Revenue This Year
  • PFO N/A
  • IRWD N/A
  • Revenue Next Year
  • PFO N/A
  • IRWD N/A
  • P/E Ratio
  • PFO N/A
  • IRWD N/A
  • Revenue Growth
  • PFO N/A
  • IRWD N/A
  • 52 Week Low
  • PFO $6.90
  • IRWD $0.53
  • 52 Week High
  • PFO $8.51
  • IRWD $7.11
  • Technical
  • Relative Strength Index (RSI)
  • PFO 72.81
  • IRWD 54.22
  • Support Level
  • PFO $9.12
  • IRWD $0.66
  • Resistance Level
  • PFO $9.23
  • IRWD $0.78
  • Average True Range (ATR)
  • PFO 0.07
  • IRWD 0.06
  • MACD
  • PFO 0.01
  • IRWD 0.01
  • Stochastic Oscillator
  • PFO 89.19
  • IRWD 83.47

About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated

Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.

About IRWD Ironwood Pharmaceuticals Inc.

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.

Share on Social Networks: